Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Black Friday is Now! Don’t miss out on up to 60% OFF InvestingPro
Claim Sale
Myriad Genetics Inc (MYGN)
Add to/Remove from a Portfolio
Add to Watchlist
7.60
-0.31
-3.92%
26/11 - Closed. Currency in USD
After Hours
7.60
0.00
0.00%
23:38:33 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 2,515,498
- Bid/Ask: 0.00 / 0.00
- Day's Range: 7.57 - 7.89
Myriad Genetics
7.60
-0.31
-3.92%
- Discussions
- Recent Sentiments
- User Rankings
MYGN User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Myriad Genetics Inc share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Gianni Italia | 1 | 1 | 1 | 100 | +44.48% |
| 2 | Vladimir Yevtushenko | 3 | 3 | 3 | 100 | +36.22% |
| 3 | иван Лоо | 2 | 2 | 2 | 100 | +28.88% |
| 4 | Artem Vishegorodtsev | 1 | 1 | 1 | 100 | +26.24% |
| 5 | Марина Сорока | 1 | 1 | 1 | 100 | +25.93% |
| 6 | Gnom Einhazad | 1 | 1 | 1 | 100 | +25.5% |
| 7 | Наталья Градова | 1 | 1 | 1 | 100 | +24.89% |
| 8 | Artem Zayats | 1 | 1 | 1 | 100 | +24.81% |
| 9 | Giovanni Feliciano | 1 | 1 | 1 | 100 | +24.47% |
| 10 | אלי דהן | 1 | 1 | 1 | 100 | +23.99% |
| 11 | Javier Larrea | 1 | 1 | 1 | 100 | +23.99% |
| 12 | JM A R | 1 | 1 | 1 | 100 | +22.28% |
| 13 | Денис Дис | 1 | 1 | 1 | 100 | +19.5% |
| 14 | Slava Afan | 2 | 2 | 1 | 50 | +18.69% |
| 15 | Maxi Robles | 1 | 1 | 1 | 100 | +15.74% |
| 16 | Tanvir Arman | 1 | 1 | 1 | 100 | +15.02% |
| 17 | Григорий Кудинов | 1 | 1 | 1 | 100 | +14.71% |
| 18 | Eugene Wu | 1 | 1 | 1 | 100 | +12.37% |
| 19 | Александр Звездин | 1 | 1 | 1 | 100 | +12.01% |
| 20 | Jerry Juneau | 1 | 1 | 1 | 100 | +11.32% |
| 21 | Иван Суханов | 1 | 1 | 1 | 100 | +10.95% |
| 22 | Светлана Гобозашвили | 1 | 1 | 1 | 100 | +8.59% |
| 23 | Дмитрий Lucky | 1 | 1 | 1 | 100 | +7.79% |
| 24 | ENRICO ALZATI | 1 | 1 | 1 | 100 | +6.66% |
| 25 | Larissa Nikitina | 2 | 2 | 2 | 100 | +6.17% |
| 26 | Brittney Madrigal | 1 | 1 | 1 | 100 | +4.75% |
| 27 | Alexey Yakunichkin | 1 | 1 | 1 | 100 | +4.23% |
| 28 | Alexandre Bavastro | 1 | 1 | 1 | 100 | +4.15% |
| 29 | NICOLA ESPOSITO | 1 | 1 | 1 | 100 | +3.01% |
| 30 | De Ma | 1 | 1 | 1 | 100 | +2.55% |
| 31 | Hillman Dag | 1 | 1 | 0 | 0 | -0.2% |
| 32 | Максим Владимирович Экстрин | 1 | 1 | 0 | 0 | -0.38% |
| 33 | Manh Auze | 1 | 1 | 0 | 0 | -0.72% |
| 34 | Marla Sanders | 1 | 1 | 0 | 0 | -0.81% |
| 35 | Ethan Endicott | 1 | 1 | 0 | 0 | -1.18% |
| 36 | ibrahim ismaeel | 1 | 1 | 0 | 0 | -1.58% |
| 37 | Артём Наседкин | 1 | 1 | 0 | 0 | -1.99% |
| 38 | Vladimir Prodan | 1 | 1 | 0 | 0 | -2.41% |
| 39 | Massimo Fracca | 1 | 1 | 0 | 0 | -3.72% |
| 40 | Neil Galloway | 1 | 1 | 0 | 0 | -4.2% |
| 41 | Владислав Богомазов | 1 | 1 | 0 | 0 | -4.45% |
| 42 | Sabir Mardanov | 1 | 1 | 0 | 0 | -4.91% |
| 43 | עומרי פרץ | 1 | 1 | 0 | 0 | -5.4% |
| 44 | Joey Nagelkerke | 1 | 1 | 0 | 0 | -6.43% |
| 45 | Chris Macdonald | 1 | 1 | 0 | 0 | -6.8% |
| 46 | Andrew Tawer | 5 | 4 | 3 | 75 | -9.81% |
| 47 | igor sadovnikov | 1 | 1 | 0 | 0 | -10.51% |
| 48 | Brendan Lam | 1 | 1 | 0 | 0 | -10.79% |
| 49 | Shankar AVSB | 1 | 1 | 0 | 0 | -17.8% |
| 50 | 宏 王 | 1 | 1 | 0 | 0 | -18.62% |
Write your thoughts about Myriad Genetics Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review